Steven Coats

1.7k total citations
28 papers, 1.3k citations indexed

About

Steven Coats is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Steven Coats has authored 28 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 11 papers in Molecular Biology and 11 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Steven Coats's work include Monoclonal and Polyclonal Antibodies Research (10 papers), HER2/EGFR in Cancer Research (7 papers) and CAR-T cell therapy research (6 papers). Steven Coats is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (10 papers), HER2/EGFR in Cancer Research (7 papers) and CAR-T cell therapy research (6 papers). Steven Coats collaborates with scholars based in United States, United Kingdom and Japan. Steven Coats's co-authors include Linda J. Van Eldik, Steven W. Barger, Jeffrey L. Staecker, Rakesh Dixit, David A. Tice, Herren Wu, Marna Williams, Leo Tseng, Jean‐Charles Soria and Nai‐Shun Yao and has published in prestigious journals such as The Journal of Cell Biology, Blood and PLoS ONE.

In The Last Decade

Steven Coats

28 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Steven Coats United States	12	628	567	461	207	187	28	1.3k
Michael Leserer Germany	4	1.2k 1.9×	576 1.0×	186 0.4×	280 1.4×	176 0.9×	4	1.9k
Jeanette Woolard United Kingdom	20	1.4k 2.3×	318 0.6×	205 0.4×	244 1.2×	126 0.7×	50	2.0k
V. Poulaki United States	17	735 1.2×	300 0.5×	192 0.4×	56 0.3×	197 1.1×	34	1.3k
David M. Nanus United States	13	442 0.7×	350 0.6×	135 0.3×	133 0.6×	88 0.5×	27	902
John Yates United Kingdom	9	918 1.5×	363 0.6×	167 0.4×	111 0.5×	129 0.7×	10	1.5k
Sergio Estrada Sweden	19	500 0.8×	139 0.2×	232 0.5×	61 0.3×	88 0.5×	47	1.1k
Sudhir B. Kondapaka United States	17	909 1.4×	495 0.9×	84 0.2×	149 0.7×	86 0.5×	21	1.5k
Federico Galvagni Italy	27	1.3k 2.0×	282 0.5×	134 0.3×	130 0.6×	215 1.1×	60	1.8k
Douglas W. Burton United States	23	810 1.3×	563 1.0×	70 0.2×	212 1.0×	69 0.4×	52	1.6k
Jiyun Yoo South Korea	23	1.2k 1.9×	413 0.7×	191 0.4×	66 0.3×	129 0.7×	53	1.8k

Countries citing papers authored by Steven Coats

Since Specialization

Citations

This map shows the geographic impact of Steven Coats's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Coats with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Coats more than expected).

Fields of papers citing papers by Steven Coats

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Coats. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Coats. The network helps show where Steven Coats may publish in the future.

Co-authorship network of co-authors of Steven Coats

This figure shows the co-authorship network connecting the top 25 collaborators of Steven Coats. A scholar is included among the top collaborators of Steven Coats based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven Coats. Steven Coats is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gitto, Sarah B., Gareth Davies, Sushil Kumar, et al.. (2023). A B7-H4–Targeting Antibody–Drug Conjugate Shows Antitumor Activity in PARPi and Platinum-Resistant Cancers with B7-H4 Expression. Clinical Cancer Research. 30(8). 1567–1581. 16 indexed citations

Wichmann, Christian, Ingrid J.G. Burvenich, Angela Rigopoulos, et al.. (2023). Preclinical radiolabeling, in vivo biodistribution and positron emission tomography of a novel pyrrolobenzodiazepine (PBD)-based antibody drug conjugate targeting ASCT2. Nuclear Medicine and Biology. 122-123. 108366–108366. 5 indexed citations

Xia, Leiming, Lu Wen, You Qin, et al.. (2021). HER2-targeted antibody-drug conjugate induces host immunity against cancer stem cells. Cell chemical biology. 28(5). 610–624.e5. 10 indexed citations

Pore, Nabendu, Kevin Schifferli, Noel R. Monks, et al.. (2018). Discovery and Development of MEDI7247, a Novel Pyrrolobenzodiazepine (PBD)-Based Antibody Drug Conjugate Targeting ASCT2, for Treating Hematological Cancers. Blood. 132(Supplement 1). 4071–4071. 7 indexed citations

Monks, Noel R., Kevin Schifferli, Ravinder Tammali, et al.. (2018). Abstract LB-295: MEDI7247, a novel pyrrolobenzodiazepine ADC targeting ASCT2 with potent in vivo activity across a spectrum of hematological malignancies. Cancer Research. 78(13_Supplement). LB–295. 6 indexed citations

Pore, Nabendu, M. Jack Borrok, Kevin Schifferli, et al.. (2018). Abstract LB-296: Discovery and development of MEDI7247, a novel Pyrrolobenzodiazepine (PBD)-based antibody drug conjugate targeting ASCT2, for treating hematological and solid cancers. Cancer Research. 78(13_Supplement). LB–296. 1 indexed citations

Schifferli, Kevin, Noel R. Monks, Ravinder Tammali, et al.. (2018). Abstract LB-298: MEDI7247: A first in class antibody drug conjugate targeting ASCT2 in a range of solid tumors. Cancer Research. 78(13_Supplement). LB–298. 6 indexed citations

Perry, Samuel R., Vanessa Muniz‐Medina, Xinzhong Wang, et al.. (2016). A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy. Cancer Cell. 29(1). 117–129. 292 indexed citations

Nyborg, Andrew C., Anna Zacco, Rachel Ettinger, et al.. (2015). Development of an antibody that neutralizes soluble IgE and eliminates IgE expressing B cells. Cellular and Molecular Immunology. 13(3). 391–400. 45 indexed citations

10.

Reichert, Janice M., Alain Beck, Alexey A. Lugovskoy, et al.. (2014). 9th Annual European Antibody Congress, November 11–13, 2013, Geneva, Switzerland. mAbs. 6(2). 309–326. 15 indexed citations

11.

Peng, Li, Michael D. Oberst, Jia‐Qi Huang, et al.. (2012). The CEA/CD3-Bispecific Antibody MEDI-565 (MT111) Binds a Nonlinear Epitope in the Full-Length but Not a Short Splice Variant of CEA. PLoS ONE. 7(5). e36412–e36412. 27 indexed citations

12.

Chesebrough, Jon, Sally‐Ann Ricketts, Margaret H. Veldman-Jones, et al.. (2011). Dual IGF-I/II–Neutralizing Antibody MEDI-573 Potently Inhibits IGF Signaling and Tumor Growth. Cancer Research. 71(3). 1029–1040. 105 indexed citations

13.

Steiner, Paul E., Kevin Schifferli, Raffaele Baffa, et al.. (2010). 100 Inhibition of PDGFRalpha in tumor stroma with MEDI-575 enhances activity of carboplatin/paclitaxel and delays tumor regrowth in a NSCLC xenograft model. European Journal of Cancer Supplements. 8(7). 39–39. 1 indexed citations

14.

Bruckheimer, Elizabeth, Christine Fazenbaker, Sandra Gallagher, et al.. (2009). Antibody-Dependent Cell-Mediated Cytotoxicity Effector-Enhanced EphA2 Agonist Monoclonal Antibody Demonstrates Potent Activity against Human Tumors. Neoplasia. 11(6). 509–IN2. 29 indexed citations

15.

Mulgrew, Kathy, David J. Stewart, Wendy L. Trigona, et al.. (2008). Bioavailability, pharmacodynamic activity, and anti-tumor efficacy of the CD19/CD3-specific BiTE antibody MEDI-538 (MT103) delivered subcutaneously in animal models. Cancer Research. 68. 2131–2131. 2 indexed citations

16.

Brissette, Catherine A., et al.. (2008). Treponema denticola does not induce production of common innate immune mediators from primary gingival epithelial cells. Oral Microbiology and Immunology. 23(6). 474–481. 30 indexed citations

17.

Coats, Steven, W. J. Pledger, Midori Awazu, & Thomas O. Daniel. (1996). Detergent solubility defines an alternative itinerary for a subpopulation of PDGF β receptors. Journal of Cellular Physiology. 168(2). 412–423. 6 indexed citations

18.

Coats, Steven, James E. Olson, & W. J. Pledger. (1992). Rapid induction of competence formation is PDGF‐isoform specific. Journal of Cellular Biochemistry. 48(3). 242–247. 10 indexed citations

19.

Coats, Steven & Norma P. Gerard. (1989). Characterization of the Substance P Receptor in Guinea Pig Lung Tissues. American Journal of Respiratory Cell and Molecular Biology. 1(4). 269–275. 11 indexed citations

20.

Shore, Stephanie A., Norma P. Stimler-Gerard, Steven Coats, & Jeffrey M. Drazen. (1988). Substance P-induced Bronchoconstriction in the Guinea Pig: Enhancement by Inhibitors of Neutral Metalloendopeptidase and Angiotensin-converting Enzyme. American Review of Respiratory Disease. 137(2). 331–336. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact